ARCHIVES

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.”

November 3, 2006

Study Seeks Sisters Of Women With Breast Cancer

September 27, 2002

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

Research Base Would Be Increased In Guideline Change

November 9, 1990

Also Weber returns to M.D. Anderson.

August 8, 2003

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

November 6, 1998